SI-BONE SIBN Stock
SI-BONE Price Chart
SI-BONE SIBN Financial and Trading Overview
| SI-BONE stock price | 23.16 USD |
| Previous Close | 23.41 USD |
| Open | 23.21 USD |
| Bid | 12.96 USD x 200 |
| Ask | 22.93 USD x 200 |
| Day's Range | 22.94 - 23.46 USD |
| 52 Week Range | 11.48 - 25.92 USD |
| Volume | 271.47K USD |
| Avg. Volume | 697.31K USD |
| Market Cap | 1.05B USD |
| Beta (5Y Monthly) | 0.617 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.31 USD |
| Forward Dividend & Yield | N/A (0%) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 26.78 USD |
SIBN Valuation Measures
| Enterprise Value | 952.64M USD |
| Trailing P/E | N/A |
| Forward P/E | -80.81195 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 4.7453885 |
| Price/Book (mrq) | 5.655458 |
| Enterprise Value/Revenue | 4.317 |
| Enterprise Value/EBITDA | -94.461 |
Trading Information
SI-BONE Stock Price History
| Beta (5Y Monthly) | 0.617 |
| 52-Week Change | 27.50% |
| S&P500 52-Week Change | 12.07% |
| 52 Week High | 25.92 USD |
| 52 Week Low | 11.48 USD |
| 50-Day Moving Average | 20.47 USD |
| 200-Day Moving Average | 16.79 USD |
SIBN Share Statistics
| Avg. Volume (3 month) | 697.31K USD |
| Avg. Daily Volume (10-Days) | 1.16M USD |
| Shares Outstanding | 45.11M |
| Float | 40.46M |
| Short Ratio | 7.33 |
| % Held by Insiders | 3.14% |
| % Held by Institutions | 111.06% |
| Shares Short | 4.53M |
| Short % of Float | 11.67% |
| Short % of Shares Outstanding | 10.02% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | September 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -6.20% |
| Operating Margin (ttm) | -7.57% |
| Gross Margin | 79.39% |
| EBITDA Margin | -4.57% |
Management Effectiveness
| Return on Assets (ttm) | -4.25% |
| Return on Equity (ttm) | -7.67% |
Income Statement
| Revenue (ttm) | 220.65M USD |
| Revenue Per Share (ttm) | 4.99 USD |
| Quarterly Revenue Growth (yoy) | 14.49% |
| Gross Profit (ttm) | 175.19M USD |
| EBITDA | -10085000 USD |
| Net Income Avi to Common (ttm) | -13686000 USD |
| Diluted EPS (ttm) | -0.31 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 146.26M USD |
| Total Cash Per Share (mrq) | 3.24 USD |
| Total Debt (mrq) | 42.8M USD |
| Total Debt/Equity (mrq) | 23.18 USD |
| Current Ratio (mrq) | 7.585 |
| Book Value Per Share (mrq) | 4.104 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 6.08M USD |
| Levered Free Cash Flow (ttm) | -1174125 USD |
Profile of SI-BONE
| Country | United States |
| State | CA |
| City | Santa Clara |
| Address | 471 El Camino Real |
| ZIP | 95050 |
| Phone | 408 207 0700 |
| Website | https://si-bone.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 376 |
SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. The company also provides IFUSE, a triangular titanium implant with a triangular cross-section and porous surface that stabilizes the joint and facilitates the biological fixation of the bone onto the implant to drive fusion; IFUSE 3D, a triangular titanium implant with a porous surface and fenestrated design to self-harvest bone; IFUSE BONE, which supports and augments the patient's own bone tissue in orthopedic procedures; IFUSE TORQ, an additively-manufactured threaded implant designed to allow for osteointegration, or incorporation of the bone into the implant's porous surface and structure; IFUSE BEDROCK GRANITE, an implant with a machined titanium core and a tulip that attaches to the rod and provides fusion and fixation to the sacroiliac joint as a foundational element for segmental spinal fusion; and IFUSE TORQ TNT, a porous threaded design with lengths capable of spanning the posterior pelvis, passing through the ipsilateral ilium, sacrum, and through the contralateral ilium. The company markets its products primarily with a direct sales force, as well as through third-party sales agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.
Q&A For SI-BONE Stock
What is a current SIBN stock price?
SI-BONE SIBN stock price today per share is 23.16 USD.
How to purchase SI-BONE stock?
You can buy SIBN shares on the Tech Market Middle exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for SI-BONE?
The stock symbol or ticker of SI-BONE is SIBN.
Which industry does the SI-BONE company belong to?
The SI-BONE industry is Medical Devices.
How many shares does SI-BONE have in circulation?
The max supply of SI-BONE shares is 45.11M.
What is SI-BONE Price to Earnings Ratio (PE Ratio)?
SI-BONE PE Ratio is now.
What was SI-BONE earnings per share over the trailing 12 months (TTM)?
SI-BONE EPS is -0.31 USD over the trailing 12 months.
Which sector does the SI-BONE company belong to?
The SI-BONE sector is Healthcare.
SI-BONE SIBN included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
|
- | |||||
US Tech Composite
IXIC
US
|
24328.38 USD — |
-0.74
|
8.59B USD — | 23989.09 USD — | 24547.66 USD — | — - | 8.59B USD — |
US Tech Global Market Composite
NQGM
US
|
1835.7 USD — |
-1.77
|
— — | 1816.36 USD — | 1866.76 USD — | — - | — — |
US Tech Health Care
IXHC
US
|
1332.89 USD — |
-0.73
|
— — | 1323.81 USD — | 1342.94 USD — | — - | — — |


